ResourcesArticlesFuture Science

Multi-Omics Biomarkers of Aging: Integrating Genomics, Epigenetics, and Proteomics

Multi-omics approaches integrate genomic, epigenetic, proteomic, and metabolomic data to better understand biological aging processes.

XELGEN Science Team
Original Article
March 2026
4 min read
Future Science
Multi-Omics Biomarkers of Aging: Integrating Genomics, Epigenetics, and Proteomics

Aging is driven by complex biological processes involving interactions across multiple molecular systems. Traditional biomarker research has often focused on single types of biological measurements — a single protein, a single genetic variant, or a single methylation clock. However, aging biology involves coordinated changes across numerous molecular layers simultaneously.

To better understand these interactions, researchers increasingly use multi-omics approaches, which integrate data from multiple biological domains to construct systems-level models of aging.

Major Omics Layers in Aging Research

Multi-omics approaches typically integrate several distinct types of biological data, each capturing a different dimension of the aging process.

Genomics

Genomics examines DNA sequence variations — including single nucleotide polymorphisms (SNPs) and copy number variants — that influence disease risk and longevity. Genome-wide association studies (GWAS) have identified hundreds of genetic loci associated with lifespan and age-related disease.

Epigenomics

Epigenomics focuses on regulatory modifications such as DNA methylation and histone modification that influence gene expression without altering DNA sequence. Epigenetic clocks derived from methylation data are among the most powerful predictors of biological age currently available.

Transcriptomics

Transcriptomics measures RNA expression levels across the genome, capturing the real-time activity of cells in response to aging, stress, and environmental exposures. Age-related changes in gene expression patterns have been documented across multiple tissues.

Proteomics

Proteomics analyzes the proteins that carry out most cellular functions. The plasma proteome changes substantially with age, and proteomic clocks have been developed that predict biological age from circulating protein levels with high accuracy.

Metabolomics

Metabolomics measures small molecules produced during metabolism, providing a real-time snapshot of physiological state. Metabolomic profiles reflect the cumulative impact of genetics, lifestyle, and environmental exposure on cellular function.

Systems Biology of Aging

When combined, these datasets allow researchers to construct systems-level models of aging that reveal how biological networks change over time. These models can identify pathways associated with longevity and disease that would not be apparent from any single data type.

  • Network analysis — mapping how molecular interactions change with age
  • Pathway enrichment — identifying biological processes consistently altered across omics layers
  • Biomarker integration — combining signals from multiple layers to improve prediction accuracy
  • Causal inference — distinguishing drivers of aging from downstream consequences

This approach is helping researchers better understand how aging processes emerge from complex molecular interactions — and identify intervention targets that may slow or reverse biological aging at the systems level.

How XELGEN Fits In

XELGEN contributes to the multi-omics framework by generating genome-wide epigenetic data through DNA methylation analysis — a key component of aging biology that reflects both genetic predisposition and environmental influences.

Explore how XELGEN epigenetic analysis supports multi-omics longevity research
Frequently Asked

What is a multi-omics approach to aging research?

Multi-omics integrates data from genomics, epigenomics, transcriptomics, proteomics, and metabolomics to build comprehensive models of biological aging — capturing interactions across molecular layers that single-biomarker approaches cannot detect.

References

  1. Johnson CH et al. Metabolomics: beyond biomarkers and towards mechanisms. Nature Reviews Molecular Cell Biology. 2016.DOI
  2. Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013.DOI
  3. Hasin Y et al. Multi-omics approaches to disease. Genome Biology. 2017.DOI
#Multiomics#LongevityScience#PrecisionMedicine#Epigenetics#SystemsBiology
Back to Resources
Continue Reading

Related Articles

View all articles
Artificial Intelligence and Biological Age Prediction
Future Science

Artificial Intelligence and Biological Age Prediction

Machine learning and multi-omics integration are transforming how we predict biological age.

5 min readRead
Why DNA Methylation Is the Leading Aging Biomarker
Epigenetics

Why DNA Methylation Is the Leading Aging Biomarker

Among all molecular biomarkers of aging, DNA methylation stands out for its precision and clinical applicability.

5 min readRead
The Future of Longevity Medicine
Future Science

The Future of Longevity Medicine

Longevity medicine is evolving through biomarker research, artificial intelligence, and precision health technologies.

4 min readRead
XELGEN Resources

© 2026 XELGEN. For licensed healthcare providers and scientific researchers only.